Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis (PSOBIOTEQ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01617018
Recruitment Status : Recruiting
First Posted : June 12, 2012
Last Update Posted : July 23, 2018
Sponsor:
Collaborators:
French Health Products Safety Agency
Société de Dermatologie Française
Janssen, LP
Pfizer
AbbVie
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : July 2020